Anthropic Run Rate Reportedly Passes $65 Billion Ahead of IPO
Claude maker outpaces OpenAI as Q2 tops $11.5B

Artificial intelligence developer Anthropic has told investors its annualized revenue run rate surpassed $65 billion by late July 2026, a fresh milestone that underscores rapid enterprise adoption of the Claude platform ahead of a planned stock market debut. The figure, drawn from investor materials and reported in business media, positions Anthropic as the current top-grossing frontier AI lab and sharpens the spotlight on its fall IPO timetable.
Key details indicate the surge reflects extraordinary second‑quarter performance. Internal tallies shared with investors show preliminary Q2 revenue of more than $11.5 billion, more than doubling from Q1’s $4.73 billion and up roughly 14‑fold from the same period a year earlier. The latest pace follows a steep climb from about $9 billion in run‑rate revenue at the end of 2025 and approximately $47 billion by May 2026. For market context, rival OpenAI recently told employees its own annualized revenue run rate is above $40 billion. Outlets also noted a caveat that the two labs may not calculate revenue metrics in the same way.
The numbers arrive as Anthropic advances toward a public listing. People familiar with the process say the company has been meeting prospective investors, with Morgan Stanley, Goldman Sachs, and JPMorgan working on the offering and timing discussed for September–October 2026. Anthropic said in June 2026 that it had confidentially submitted draft registration documents to the SEC, signaling the formal process was underway.
Context from the past quarter helps explain investor focus. Anthropic’s late‑May 2026 funding round raised $65 billion at a $965 billion post‑money valuation and was accompanied by disclosures that its run‑rate had already crossed $47 billion. Subsequent reporting indicates enterprise demand for coding agents and large‑scale model deployments has remained the chief revenue driver, even as cost efficiency and measurement differences have become competitive flash points among leading labs.